Lee Chan Henry
SEC CIK 1980648 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | SVP, GC | 2,666 | — | $16.39M | 45 | 2023-06-15 | 2026-08-11 |
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-13 20:54 | 2026-08-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.37 | +2,666 | 2,666 | New | +$510.2K |
| DT | 2026-08-13 20:54 | 2026-08-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $360.00 | -2,666 | 0 | -100% | -$959.8K |
| 2026-08-03 17:18 | 2026-07-30 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $323.69 | -1,044 | 0 | -100% | -$337.9K | |
| DMT | 2026-07-24 16:51 | 2026-07-22 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.58 | +1,669 | 1,669 | New | +$319.7K |
| DT | 2026-07-24 16:51 | 2026-07-22 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $325.00 | -1,669 | 0 | -100% | -$542.4K |
| DMT | 2026-07-10 16:44 | 2026-07-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 664 | New | +$127.2K |
| DT | 2026-07-10 16:44 | 2026-07-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $302.46 | -664 | 0 | -100% | -$200.8K |
| 2026-06-18 17:19 | 2026-06-16 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $265.98 | -590 | 0 | -100% | -$156.9K | |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +45.1K | 346.6K | +15% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $257.63 | -428 | 0 | -100% | -$110.3K |
| M | 2026-06-10 17:26 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $270.42 | -871 | 0 | -100% | -$235.5K |
| DMT | 2026-05-15 16:39 | 2026-05-13 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +332 | 332 | New | +$63.6K |
| DT | 2026-05-15 16:39 | 2026-05-13 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $310.72 | -332 | 0 | -100% | -$103.2K |
| DMT | 2026-04-10 17:40 | 2026-04-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +332 | 332 | New | +$63.6K |
| DT | 2026-04-10 17:40 | 2026-04-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $311.59 | -332 | 0 | -100% | -$103.4K |
| DM | 2026-03-13 | 2026-03-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.64 | +341 | 341 | New | +$65.3K |
| D | 2026-03-13 | 2026-03-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $300.00 | -341 | 0 | -100% | -$102.3K |
| M | 2026-03-10 | 2026-03-06 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +95.3K | 318.4K | +43% | $0 |
| DM | 2026-02-06 | 2026-02-04 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.40 | +1,660 | 1,660 | New | +$317.7K |
| DM | 2026-02-06 | 2026-02-04 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $349.52 | -1,660 | 996 | -62% | -$580.2K |
| DM | 2026-01-09 | 2026-01-07 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 664 | New | +$127.2K |
| D | 2026-01-09 | 2026-01-07 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $331.76 | -664 | 0 | -100% | -$220.3K |
| DM | 2025-12-12 | 2025-12-10+ | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 332 | New | +$127.2K |
| DM | 2025-12-12 | 2025-12-10+ | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $321.64 | -664 | 0 | -100% | -$213.6K |
| DM | 2025-11-14 | 2025-11-12 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $349.17 | -996 | 0 | -100% | -$347.8K |
| DM | 2025-11-14 | 2025-11-12 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $191.47 | +996 | 996 | New | +$190.7K |
| DM | 2025-10-10 | 2025-10-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $350.40 | -10.7K | 4,162 | -72% | -$3.74M |
| DM | 2025-10-10 | 2025-10-08 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $211.04 | +9,559 | 9,559 | New | +$2.02M |
| DM | 2025-09-12 | 2025-09-10 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $197.10 | +8,894 | 8,598 | New | +$1.75M |
| DM | 2025-09-12 | 2025-09-10 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $325.53 | -10.0K | 500 | -95% | -$3.26M |
| DM | 2025-08-15 | 2025-08-13 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | M - OptEx | $177.90 | +8,230 | 8,230 | New | +$1.46M |
| DM | 2025-08-15 | 2025-08-13 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $300.45 | -11.0K | 0 | -100% | -$3.31M |
| 2025-07-31 | 2025-07-30 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $304.60 | -920 | 0 | -100% | -$280.2K | |
| 2025-06-18 | 2025-06-16 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $266.50 | -422 | 0 | -100% | -$112.5K | |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +46.9K | 283.9K | +20% | $0 |
| M | 2025-06-10 | 2025-06-06 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $256.11 | -700 | 0 | -100% | -$179.3K |
| 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +40.2K | 246.1K | +20% | $0 | |
| 2025-03-03 | 2025-02-27 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $275.00 | -1,205 | 0 | -100% | -$331.4K | |
| M | 2025-02-25 | 2025-02-21 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $258.04 | -1,202 | 0 | -100% | -$310.2K |
| 2024-10-02 | 2024-09-30 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $237.10 | -1,202 | 0 | -100% | -$285.0K | |
| 2024-08-01 | 2024-07-30 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $160.57 | -834 | 0 | -100% | -$133.9K | |
| M | 2024-06-20 | 2024-06-17 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $159.35 | -439 | 129 | -77% | -$70.0K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +98.1K | 269.4K | +57% | $0 |
| 2023-08-02 | 2023-07-31 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale | $216.26 | -791 | 0 | -100% | -$171.1K | |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +65.6K | 181.6K | +57% | $0 |
Purchase Sale Sale after option exercise All abbreviations